Log on / register
Feedback | Support | My details
Overview of phase I studies of intravenous administration of PV701, an oncolytic virus
RM Lorence, AL Pecora, PP Major, SJ Hotte, SA Laurie, MS Roberts, WS Groene, MK Bamat
Current Opinion in Molecular Therapeutics 2003 5:618-624
Access to the full text of this article requires a subscription. If you would like information about a personal subscription, please contact info@currentdrugs.com.
Log in Existing subscribers login

Email address
Password 
 
 
Forgotten your password?
Purchase this article Purchase this article
Recommend to your librarian Recommend to your librarian
Log in via Athens Log in via Athens

Thomson Scientific Journals are available through the BioMed Central platform and feature high quality reviews as well as paper, patent and web alerts to provide accurate and timely information on developments in drug R&D. Covering over 400 scientific meetings per year as well as the most important developments in their subject areas, the Thomson Scientific Journals provide a practical way of staying on top of the latest developments.

Current Opinion in Molecular Therapeutics provides a broad and clearly defined coverage of all major areas of research in the field of molecular medicine, covering:

  • Topics suggested by our wide Editorial Board
  • Comment on the latest discoveries
  • Opinions on the latest disclosures in scientific literature

If you are registered and have trouble logging in, email us: info@biomedcentral.com

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.